AN1 12.5% 0.7¢ anagenics limited

Ann: Appendix 4E and FY21 Financial Report, page-59

  1. 475 Posts.
    lightbulb Created with Sketch. 214
    For 3 days running, the continous rumbling of speculations and forward statements have not produced any earthquakes or eruptions we were hoping for. On the contrary, the SP has remained at 5.2 cents a share, very very low and total volumes traded is almost zero.

    May be investors do not see what others see or are totally unconvinced having seen no progress and their investments continuously dropping to now 5 percent of original value.

    Many in this forum including myself do not believe that the company will be profitable this financial year or in the near future. But we sincerely believe that if the company cuts down on salaries and administration costs, reduces the number of senior personnel, the company will be profitable in one single quarter and continuously thereafter. Nobody believes in Cellmid's forward statements. They never materialize. We all know it but refuse to admit.

    Oh well it is good to have hope. That is the only thing left for us.
 
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
(20min delay)
Last
0.7¢
Change
-0.001(12.5%)
Mkt cap ! $3.229M
Open High Low Value Volume
0.7¢ 0.7¢ 0.7¢ $91 13K

Buyers (Bids)

No. Vol. Price($)
4 620225 0.7¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 615000 4
View Market Depth
Last trade - 11.59am 24/06/2024 (20 minute delay) ?
AN1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.